Company Operations - The company has not engaged in any operations or generated any revenues to date, with activities limited to organizational tasks and identifying a target company for a Business Combination [108]. - As of March 31, 2025, the company did not incur a net loss [109]. Initial Public Offering (IPO) - The Initial Public Offering (IPO) generated gross proceeds of $200,000,000 from the sale of 20,000,000 Units at a price of $10.00 per Unit [112]. - Transaction costs incurred during the IPO amounted to $2,105,782, which included a $1,000,000 underwriting fee [114]. - A total of $200,000,000 was placed in the Trust Account following the IPO [114]. - The underwriters were entitled to a cash underwriting discount of $1,000,000, which was paid upon the closing of the IPO [121]. Financial Position - The company completed a private sale of 2,648,000 Private Placement Warrants at a price of $1.00 per warrant, generating gross proceeds of $2,648,000 [113]. - The company intends to use substantially all funds in the Trust Account to complete its initial Business Combination [115]. - The company has no long-term debt, capital lease obligations, or long-term liabilities as of March 31, 2025 [120]. - The company has no off-balance sheet arrangements or critical accounting estimates to disclose as of March 31, 2025 [119][123].
Vendome Acquisition Corp I Unit(VNMEU) - 2025 Q1 - Quarterly Report